{
    "Rank": 438,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT03168971",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "18-542"
                },
                "SecondaryIdInfoList": {
                    "SecondaryIdInfo": [
                        {
                            "SecondaryId": "5K23AG048632",
                            "SecondaryIdType": "U.S. NIH Grant/Contract",
                            "SecondaryIdLink": "https://reporter.nih.gov/quickSearch/5K23AG048632"
                        }
                    ]
                },
                "Organization": {
                    "OrgFullName": "Memorial Sloan Kettering Cancer Center",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Managing Anxiety From Cancer (MAC): Testing an Intervention for Anxiety in Older Adults With Cancer and Their Caregivers",
                "OfficialTitle": "Managing Anxiety From Cancer (MAC): A Pilot Randomized Controlled Trial of a Psychological Intervention for Anxiety in Older Adults With Cancer and Their Caregivers"
            },
            "StatusModule": {
                "StatusVerifiedDate": "February 2023",
                "OverallStatus": "Active, not recruiting",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "January 23, 2019",
                    "StartDateType": "Actual"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "January 21, 2024",
                    "PrimaryCompletionDateType": "Anticipated"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "January 21, 2024",
                    "CompletionDateType": "Anticipated"
                },
                "StudyFirstSubmitDate": "May 23, 2017",
                "StudyFirstSubmitQCDate": "May 25, 2017",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "May 30, 2017",
                    "StudyFirstPostDateType": "Actual"
                },
                "LastUpdateSubmitDate": "February 27, 2023",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "February 28, 2023",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Sponsor"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Memorial Sloan Kettering Cancer Center",
                    "LeadSponsorClass": "OTHER"
                },
                "CollaboratorList": {
                    "Collaborator": [
                        {
                            "CollaboratorName": "Weill Medical College of Cornell University",
                            "CollaboratorClass": "OTHER"
                        },
                        {
                            "CollaboratorName": "National Institute on Aging (NIA)",
                            "CollaboratorClass": "NIH"
                        }
                    ]
                }
            },
            "OversightModule": {
                "OversightHasDMC": "No",
                "IsFDARegulatedDrug": "No",
                "IsFDARegulatedDevice": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "This study is being done to test the effects of Managing Anxiety from Cancer (MAC) therapy on anxiety compared to usual care, in patients and their caregivers. MAC is different from usual care because it uses a plan for managing anxiety that has been shown to work in previous studies. MAC has designed this plan for people 65 years of age and older. MAC also includes the primary caregiver which has been shown to help patients manage their anxiety."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Anxiety",
                        "Depression",
                        "Quality of Life"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "Cancer",
                        "Anxiety",
                        "Cognitive behavior therapy",
                        "Elderly",
                        "Caregivers",
                        "18-542"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Interventional",
                "PhaseList": {
                    "Phase": [
                        "Not Applicable"
                    ]
                },
                "DesignInfo": {
                    "DesignAllocation": "Randomized",
                    "DesignInterventionModel": "Parallel Assignment",
                    "DesignInterventionModelDescription": "Patient-caregiver dyads will be randomly assigned to the intervention or a usual care control condition.",
                    "DesignPrimaryPurpose": "Treatment",
                    "DesignMaskingInfo": {
                        "DesignMasking": "Single",
                        "DesignWhoMaskedList": {
                            "DesignWhoMasked": [
                                "Outcomes Assessor"
                            ]
                        }
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "26",
                    "EnrollmentType": "Actual"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Managing Anxiety from Cancer (MAC)",
                            "ArmGroupType": "Experimental",
                            "ArmGroupDescription": "Older adults with cancer and their primary informal caregiver will receive a seven-session cognitive-behavior therapy intervention administered over the telephone by a trained study interventionist. The intervention is administered weekly and each session is 45-50 minutes in length. Patients and caregivers will receive the intervention independently and from separate therapists.",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Behavioral: Managing Anxiety from Cancer (MAC)"
                                ]
                            }
                        },
                        {
                            "ArmGroupLabel": "Usual Care",
                            "ArmGroupType": "No Intervention",
                            "ArmGroupDescription": "Older adults with cancer and their primary informal caregiver will receive standard care provided by their medical team. These participants will not receive any intervention from the research team."
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Behavioral",
                            "InterventionName": "Managing Anxiety from Cancer (MAC)",
                            "InterventionDescription": "The intervention consists of seven telephone-administered sessions. Session topics include psychoeducation on anxiety, behavioral strategies for managing anxiety, cognitive restructuring, communication skills training, acceptance techniques, problem-solving strategies, and planning for future anxiety. Session content is tailored for older adults and caregivers of older adults with cancer.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Managing Anxiety from Cancer (MAC)"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Anxiety sub-scale of the Hospital Anxiety and Depression Scale",
                            "PrimaryOutcomeDescription": "Change in anxiety from baseline to follow-up",
                            "PrimaryOutcomeTimeFrame": "Baseline (1-2 weeks after enrollment) and Follow-up (7-9 weeks after baseline)"
                        },
                        {
                            "PrimaryOutcomeMeasure": "Hamilton Anxiety Rating Scale",
                            "PrimaryOutcomeDescription": "Change in anxiety from baseline to follow-up",
                            "PrimaryOutcomeTimeFrame": "Baseline (1-2 weeks after enrollment) and Follow-up (7-9 weeks after baseline)"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Depression sub-scale of the Hospital Anxiety and Depression Scale",
                            "SecondaryOutcomeDescription": "Change in depression from baseline to follow-up",
                            "SecondaryOutcomeTimeFrame": "Baseline (1-2 weeks after enrollment) and Follow-up (7-9 weeks after baseline)"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Distress Thermometer",
                            "SecondaryOutcomeDescription": "Change in distress from baseline to follow-up",
                            "SecondaryOutcomeTimeFrame": "Baseline (1-2 weeks after enrollment) and Follow-up (7-9 weeks after baseline)"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Functional Assessment of Cancer Therapy-General: Emotional Quality of Life Sub-Scale (patients only)",
                            "SecondaryOutcomeDescription": "Change in health-related quality of life",
                            "SecondaryOutcomeTimeFrame": "Baseline (1-2 weeks after enrollment) and Follow-up (7-9 weeks after baseline)"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Caregiver Quality of Life-Cancer (caregivers only)",
                            "SecondaryOutcomeDescription": "Change in health-related quality of life",
                            "SecondaryOutcomeTimeFrame": "Baseline (1-2 weeks after enrollment) and Follow-up (7-9 weeks after baseline)"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Montgomery-Asberg Depression Scale",
                            "SecondaryOutcomeDescription": "Change in depression from baseline to follow-up",
                            "SecondaryOutcomeTimeFrame": "Baseline (1-2 weeks after enrollment) and Follow-up (7-9 weeks after baseline)"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nPATIENTS:\n\nAge 65 or older\nConfirmed diagnosis of breast, lymphoma, genitourinary, thoracic, gynecological or gastrointestinal cancer, currently on active treatment or within six months of completion of treatment\nAs determined by the patient's primary oncologist and/or study staff, physically and cognitively able to complete study procedures\nEnglish fluent (as per self-reported fluency of \"very well\")**\nIn the judgment of the investigators and/or consenting professional, able to perform informed consent\nHas a primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) who is willing and able to participate in the study\nAs part of the patient-caregiver dyad, at least one member reports elevated anxiety as defined by a score of 8 or greater on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS)\nAs per self-report, residency in New York or ability to complete sessions in New York\nAble to communicate over the phone for sessions\nWillingness to be audio-recorded for assessments and, if applicable, study sessions\n\nCAREGIVERS:\n\nAge 21 or older\nIn the judgment of the investigators and/or consenting professional, able to perform informed consent\nAs part of the patient-caregiver dyad, at least one member reports elevated anxiety as defined by a score of 8 or greater on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS)\nEnglish fluent (as per self-reported fluency of \"very well\")**\nIs a primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) for an MSK patient\nAs per self-report, residency in New York or ability to complete sessions in New York\nAble to communicate over the phone for sessions\nWillingness to be audio-recorded for assessments and, if applicable, study sessions\n\nExclusion Criteria:\n\nPATIENTS:\n\nEndorsing active suicidal ideation on the item, \"In light of your current circumstances, have you ever had thoughts of killing yourself?\"\nAs per oncologist or self-report, too weak or cognitively impaired to participate in the intervention and complete the assessments\nPer self-report/screening measures, has received cognitive-behavioral therapy since cancer diagnosis\nAs per medical record or self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder\nAnxiety due solely to a medical procedure as determined by a patient-report item on the screening questionnaire\n\nCAREGIVERS:\n\nEndorsing active suicidal ideation on the item, \"In light of your current circumstances, have you ever had thoughts of killing yourself?\"\nPer self-report/screening measures, has received cognitive-behavioral therapy since patient\"s cancer diagnosis\nAs per self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder\nIf female, currently pregnant",
                "HealthyVolunteers": "Accepts Healthy Volunteers",
                "Gender": "All",
                "MinimumAge": "21 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                }
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Kelly Trevino, PhD",
                            "OverallOfficialAffiliation": "Memorial Sloan Kettering Cancer Center",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Memorial Sloan Kettering Cancer Center",
                            "LocationCity": "New York",
                            "LocationState": "New York",
                            "LocationZip": "10065",
                            "LocationCountry": "United States"
                        }
                    ]
                }
            },
            "ReferencesModule": {
                "SeeAlsoLinkList": {
                    "SeeAlsoLink": [
                        {
                            "SeeAlsoLinkLabel": "Memorial Sloan Kettering Cancer Center",
                            "SeeAlsoLinkURL": "http://www.mskcc.org"
                        }
                    ]
                }
            },
            "IPDSharingStatementModule": {
                "IPDSharing": "Yes",
                "IPDSharingDescription": "Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made following one year after publication and for up to 36 months later. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org."
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000001008",
                            "ConditionMeshTerm": "Anxiety Disorders"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000001523",
                            "ConditionAncestorTerm": "Mental Disorders"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M6748",
                            "ConditionBrowseLeafName": "Depression",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M6751",
                            "ConditionBrowseLeafName": "Depressive Disorder",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M4014",
                            "ConditionBrowseLeafName": "Anxiety Disorders",
                            "ConditionBrowseLeafAsFound": "Anxiety",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M4505",
                            "ConditionBrowseLeafName": "Mental Disorders",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M14163",
                            "ConditionBrowseLeafName": "Psychotic Disorders",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "T6034",
                            "ConditionBrowseLeafName": "Quality of Life",
                            "ConditionBrowseLeafAsFound": "Quality of Life",
                            "ConditionBrowseLeafRelevance": "high"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BXM",
                            "ConditionBrowseBranchName": "Behaviors and Mental Disorders"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        }
                    ]
                }
            }
        }
    }
}